X
    X
    X
    X

    Boston Team Advises Zosano Pharma in Partnership with Asahi Kasei Pharmaceuticals

    News

     

    On October 10, 2011, Zosano Pharma Inc. announced that it has granted Asahi Kasei Pharmaceuticals Corp. the exclusive right in Asia to the Zosano transdermal parathyroid hormone patch for treating severe osteoporosis. Kathleen Williams, a Boston-based Life Sciences partner at Edwards Wildman Palmer, and Amy Decloux, an associate, assisted Zosano in defining and providing the intellectual property rights around the technology. Asahi will begin clinical trials in Japan in 2012.

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.